Both in Pharmaceuticals
Korsana Biosciences vs AnaptysBio
Over the past year KRSA returned −0.8% and ANAB returned −12.9%; their daily moves had a correlation of 0.21.
KRSA −0.8% ANAB −12.9%Growth of $1, one year, split-adjusted
| Metric | KRSA | ANAB |
|---|---|---|
| Price | $31.66 | $46.91 |
| Market cap | $1.44B | $1.40B |
| Today | +5.04% | −2.84% |
| 1 month | +3.8% | −3.3% |
| 6 months | — | −32.8% |
| Year to date | — | −3.2% |
| 1 year | — | +28.6% |
| Revenue growth (YoY) | — | −8.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −206.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.0× |
| Net cash | — | $286.5M |
| Dividend yield | — | — |
| Volatility (60d) | — | 41.0% |
| Short % of float | 1.0% | 30.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).